))
#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories
Manage episode 485273414 series 3478706
Content provided by Slice of Healthcare LLC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Slice of Healthcare LLC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.
What you'll get out of this episode:
- Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
- The company’s patented technology improves absorption via buccal and GI routes.
- First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
- Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
- Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
48 episodes
Share
